Jimmy Butts is the Chief Investment Strategist for Maximum Profit and Capital Wealth Letter, and a regular contributor to StreetAuthority Insider. Prior to joining StreetAuthority, Jimmy came from the financial services and banking industry where he worked as a Financial Advisor. There he specialized in providing customized retirement solutions for individuals. Jimmy graduated from Boise State University with a degree in business administration and finance. He also spent multiple years studying language, international business and finance in both Germany and Buenos Aires, Argentina. At one point he held his series 6, 63, 65 and 26 securities licenses. When he's not combing through financial statements or reading about finance, Jimmy enjoys being outdoors.
Analyst Articles
If you've followed my analysis for a while, then you know I'm big on helping investors prepare for times like this... Read More
If you've followed my analysis for a while, then you know I'm big on helping investors prepare for times like this... Read More
Don’t listen to the talking heads. Here’s the dirty little secret about long-term investing they don't want you to know... Read More
Don’t listen to the talking heads. Here’s the dirty little secret about long-term investing they don't want you to know... Read More
In May 2018, the Supreme Court quietly overturned a landmark piece of legislation that is opening up a previously off-limits industry. Here's how to profit... Read More
In May 2018, the Supreme Court quietly overturned a landmark piece of legislation that is opening up a previously off-limits industry. Here's how to profit... Read More
I'm going to tell you about our other "hot potato" pick, since it's one we've written about for years. So if you're ready, let's take a look... Read More
I'm going to tell you about our other "hot potato" pick, since it's one we've written about for years. So if you're ready, let's take a look... Read More
From the outset, investing seems simple enough. But in practice, it can be much different... Read More
From the outset, investing seems simple enough. But in practice, it can be much different... Read More
Biologic drugs are a game-changer. Demand isn’t going to slow down anytime soon, and Big Pharma needs companies like this one to continue developing innovative treatments... Read More
Biologic drugs are a game-changer. Demand isn’t going to slow down anytime soon, and Big Pharma needs companies like this one to continue developing innovative treatments... Read More
The streaming wars are heating up… And no, I'm not talking about Netflix vs your cable company. Here's why it matters -- and how you can profit... Read More
The streaming wars are heating up… And no, I'm not talking about Netflix vs your cable company. Here's why it matters -- and how you can profit... Read More
There's one thing I'll be keeping a close eye on to tell me if these new market highs have the strength to continue marching higher -- or if there's weakness lurking beneath the surface... Read More
There's one thing I'll be keeping a close eye on to tell me if these new market highs have the strength to continue marching higher -- or if there's weakness lurking beneath the surface... Read More
Now only should it benefit from the election season, it’s also one of the most undervalued stocks I’ve come across in quite some time... Read More
Now only should it benefit from the election season, it’s also one of the most undervalued stocks I’ve come across in quite some time... Read More
It’s clear that America’s infrastructure is in deep disrepair. And this stock could benefit from a major effort to fix the problem... Read More
It’s clear that America’s infrastructure is in deep disrepair. And this stock could benefit from a major effort to fix the problem... Read More
